接种甲型H1N1流感疫苗致晕针1例报告

下载PDF

导出

摘要 2009年12月西林县疾病预防控制中心在为全县重点人群应急预防接种H1V1流感（简称甲流）疫苗过程中，发生1例晕厥副反应。现将调查处理及结果报告如下。

作者张光筋韦李明农快妹

机构地区广西西林县疾病预防控制中心

出处《应用预防医学》 2012年第4期F0003-F0003,共1页 Applied Preventive Medicine

关键词流感疫苗预防接种疾病预防控制中心晕针甲型 2009年重点人群西林县

参考文献1

1张雪峰,孟繁岳,潘红星,胡月梅,刘文东,庄菱,林小军,席佩,杨建国,张翔,朱凤才.甲型H1N1流感病毒裂解疫苗安全性和免疫原性初步研究[J].江苏预防医学,2010,21(2):21-25. 被引量：3

1WHO. New influenza A (H1N1) virus: global epidemiologic situation[J]. Wkly Epidemiol Rec, 2009, 84:249-257.
2WHO. Pandemic (H1N1) 2009-update 63[EB/OL]. [2009]. http://www, who. int/csr/don/2009_08_28/en/index, html.
3Kathy Hancoc, Vic Veguilla, Xiuhua Lu, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus [J]. Available at: www. nejm. org September 10, 2009 (10. 1056/NEJMoa0906453).
4Michael E. Greenberg, Michael H. Lai, M. B, et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine preliminary report[J]. Available at: www. nejrn, org October 29, 2009 (10. 1056/NEJMoa0907413).
5Talbot HK, Keitel W, Cate TR, et al. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine[J]. Vaccine,2008,26: 4 057-4 061.
6European Committee for Proprietary Medicinal Products. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application (CPMP/VEG/4717/03) [S]. European Agency for the Evaluation of Medicinal Products, 2004.
7US Food and Drug Administration. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vac cines[S]. Available at:http://www, fda. gov/cber/gdlns/panfluvac, htm. Accessed 4 January 2008.

应用预防医学

2012年第4期

内容加载中请稍等...